Publication
Alterations in lipid profile and enzymes paraoxonase and butyrylcholinesterase in CBS-deficient patients
| dc.contributor.author | Vanzin, Camila | |
| dc.contributor.author | Nogueira, Célia | |
| dc.contributor.author | Vilarinho, Laura | |
| dc.contributor.author | Wajner, Moacir | |
| dc.contributor.author | Wyse, Angela | |
| dc.contributor.author | Vargas, Carmen | |
| dc.date.accessioned | 2015-02-09T16:11:49Z | |
| dc.date.available | 2015-02-09T16:11:49Z | |
| dc.date.issued | 2014-03-20 | |
| dc.description.abstract | Homocystinuria is an inborn error of metabolism most frequently caused by cystathionine β-synthase (CBS) deficiency. Homocysteine (Hcy), methionine (Met) and other metabolites of Hcy accumulate in the body of affected patients, leading to clinical manifestations such as dislocation of the optic lents, osteoporosis, mental retardation, and thromboembolism. Despite the fact that thromboembolism represent the major cause of morbidity and the most frequent cause of death in CBS-deficient patients, the cause of cardiovascular changes found in homocystinuria remain unclear. In this work, we evaluated the lipid profile (total cholesterol, HDL cholesterol, LDL cholesterol, oxidized LDL cholesterol, apolipoprotein A-1) and the activities of the enzymes paraoxonase (PON1) and butyrylcholinesterase (BuChE) in plasma of patients with homocystinuria due CBS deficiency, at diagnosis and during the treatment. It was verified a significant decrease in HDL cholesterol and apolipoprotein A1 levels in the both groups of CBS-deficient patients (at diagnosis and under treatment) when compared to controls. PON1 activity was also significantly lower in the both groups of CBS-deficient patients when compared to controls which may be related with an Hcy-dependent oxidation of any group important to catalytic activity of the enzyme that favors the atherogenesis. BuChE activity was significantly increased only in CBS-deficient patients at diagnosis and it is known that this enzymatic activity is positively associated with cardiovascular risk factors. Evaluated together, our results demonstrated that treated or not CBS-deficient patients presented important alterations in lipid metabolism. This work contributes to the understanding of the responsible mechanisms of vascular lesions in CBS-deficient patients. | por |
| dc.description.sponsorship | Apoio: CNPq, FAPERGS, CAPES, FIPE/HCPA | por |
| dc.identifier.uri | http://hdl.handle.net/10400.18/2821 | |
| dc.language.iso | eng | por |
| dc.subject | Doenças Genéticas | por |
| dc.subject | Homocystinuria | por |
| dc.subject | Cystathionine β-synthase | por |
| dc.title | Alterations in lipid profile and enzymes paraoxonase and butyrylcholinesterase in CBS-deficient patients | por |
| dc.type | conference object | |
| dspace.entity.type | Publication | |
| oaire.citation.conferencePlace | Cascais, Portugal | por |
| oaire.citation.title | 10th International Symposium SPDM, 20-21Março 2014 | por |
| rcaap.rights | openAccess | por |
| rcaap.type | conferenceObject | por |